Treatment

Epirubicin 50 mg HEXAL® Injektionslösung, 2 mg/ml, Isotonische Kochsalzlösung Fresenius clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingTherapeutic exploratory (Phase II)
Epirubicin for the Treatment of Sepsis & Septic Shock
This study is testing a medicine called Epirubicin for people in hospital with a serious infection called sepsis. Doctors want to see if it's safe and helps improve their condition. It's an early-stage study to learn more about the medicine's effects.
For: Patients with sepsis or septic shock, currently hospitalized at the Intensive Care Unit (ICU) or Intermediate Care (IMC) regardless where the sepsis was first diagnosed.
Germany